Platelet activation and atherothrombosis

New England Journal of Medicine

Volumn 358, Issue 15, 2008, Pages 1638-1639

  Kapoor, John R ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ARTERY COMPLIANCE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY THROMBOSIS; CORONARY RISK; HEART INFARCTION; HEART REINFARCTION; HUMAN; LETTER; LOADING DRUG DOSE; PRIORITY JOURNAL; RISK REDUCTION; ST SEGMENT ELEVATION; STROKE; THERAPY EFFECT; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULAR PATENCY;

EID: 42049086310     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc080056     Document Type: Letter

References (4)

1. Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;357:2482-94.
2. Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20. [Erratum, JAMA 2003;289:987.]
3. Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005;352:1179-89.
4. Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1607-21.